quinoxalines has been researched along with Biliary Cirrhosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Kakizaki, S; Kizawa, K; Kosone, T; Marubashi, K; Sato, K; Takagi, H; Takakusagi, S; Uraoka, T; Yokoyama, Y | 1 |
Fianchi, F; Pompili, M; Ponziani, FR | 1 |
Carter, EP; McMurtry, IF; Morio, Y; Sato, K | 1 |
1 review(s) available for quinoxalines and Biliary Cirrhosis
Article | Year |
---|---|
Primary biliary cholangitis development after hepatitis C virus eradication with direct acting antivirals: a case report and review of the literature.
Topics: Aged, 80 and over; Antiviral Agents; Benzofurans; Drug Combinations; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis, Biliary; Male; Quinoxalines | 2020 |
2 other study(ies) available for quinoxalines and Biliary Cirrhosis
Article | Year |
---|---|
Successful treatment with glecaprevir/pibrentasvir for chronic hepatitis C complicated by primary biliary cholangitis.
Topics: Aged; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Female; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Liver Cirrhosis, Biliary; Proline; Pyrrolidines; Quinoxalines; Sulfonamides | 2020 |
Inhibition of K(Ca) channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis.
Topics: Animals; Apamin; Charybdotoxin; Common Bile Duct; Endothelin-1; Enzyme Inhibitors; Gene Expression Regulation; Liver Cirrhosis, Biliary; Lung; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Oxadiazoles; Potassium Chloride; Pulmonary Artery; Quinoxalines; Rats; Rats, Sprague-Dawley; Transcription, Genetic; Vasoconstriction | 2000 |